UBS O'Connor’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-39,868
Closed -$63.8K 304
2025
Q1
$63.8K Sell
39,868
-97,492
-71% -$156K ﹤0.01% 232
2024
Q4
$494K Buy
137,360
+114,360
+497% +$412K 0.01% 272
2024
Q3
$131K Buy
+23,000
New +$131K ﹤0.01% 370